Literature DB >> 1635340

Glomerular hemodynamics and eicosanoid synthesis in a rat model of IgA nephropathy.

L Gesualdo1, S N Emancipator, C Kesselheim, M E Lamm.   

Abstract

We sought to study glomerular pathophysiology in a model of IgA nephropathy (IgAN). Preliminary experiments with oral immunization indicated that Lewis rats had higher IgA levels and IgA/IgG ratios than Wistar, Fischer or Sprague-Dawley rats. Six groups of Lewis rats were studied: four continuously orally immunized for eight weeks with bovine gamma globulin (BGG) in the drinking water, the other two non-immunized controls. Groups of immunized rats were treated with a thromboxane receptor antagonist (SQ 29,485) and/or a thromboxane synthase inhibitor (UK 38,485). After systemic challenge, microscopic hematuria was present in 84% of immunized rats not given anti-thromboxane drugs versus 18% of non-immunized rats (P less than 0.01). Immunized rats showed predominantly IgA glomerular deposits with lesser IgG and C3, and produced more glomerular thromboxane than controls, but no significant increase in prostaglandin E2. Immunized rats also had reduced GFR and RPF, but not a reduced filtration fraction, compared to controls. Thromboxane synthase inhibitor diminished glomerular thromboxane and increased prostaglandin E2 in immunized rats. Anti-thromboxane therapy reduced hematuria and apparently re-established the RPF but not the GFR in immunized rats, yielding a reduced filtration fraction. We propose that increased thromboxane, in concert with mesangial contraction that is unaffected by anti-thromboxane drugs, contributes to the pathophysiology in this model of IgAN.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1635340     DOI: 10.1038/ki.1992.268

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

1.  T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation.

Authors:  S R Chintalacharuvu; N U Nagy; N Sigmund; J G Nedrud; M E Amm; S N Emancipator
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

2.  Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy.

Authors:  Kar Neng Lai; Loretta Y Y Chan; Hong Guo; Sydney C W Tang; Joseph C K Leung
Journal:  Pediatr Nephrol       Date:  2010-12-02       Impact factor: 3.714

Review 3.  Immunopathogenesis of experimental IgA nephropathy.

Authors:  A Rifai
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Quantitative ultrastructural study of afferent and efferent arterioles in IgA glomerulonephritis and benign nephrosclerosis.

Authors:  Z Rázga; B Iványi; N Zidar; D Ferluga; S Sonkodi; J Ormos
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

5.  Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop.

Authors:  T S Kern; C M Miller; J Tang; Y Du; S L Ball; L Berti-Matera
Journal:  Mol Vis       Date:  2010-08-15       Impact factor: 2.367

6.  Toll-like Receptor 4 Signaling Pathway in the Protective Effect of Pioglitazone on Experimental Immunoglobulin A Nephropathy.

Authors:  Jia-Nan Zou; Jing Xiao; Sha-Sha Hu; Chen-Sheng Fu; Xiao-Li Zhang; Zhen-Xing Zhang; Yi-Jun Lu; Wei-Jun Chen; Zhi-Bin Ye
Journal:  Chin Med J (Engl)       Date:  2017-04-20       Impact factor: 2.628

Review 7.  Unresolved issues and current concepts in management of primary glomerulonephritis.

Authors:  Suresh Chandra Dash; Fahd A Al-Muhanna
Journal:  Ann Saudi Med       Date:  2005 Jul-Aug       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.